Theradex

Theradex was founded in 1982 with the award of the Clinical Trials Monitoring Service contract for the National Cancer Institute (NCI) in the United States. The Clinical Trial Monitoring Service provides central data management and monitoring services for early phase cancer trials sponsored by the NCI. In 2014, the services expanded to support trials conducted under the NCI Experimental Therapeutics Clinical Trials Network (ETCTN). Theradex’s support of NCI programs also includes audits of NCI-supported cancer center programs participating in NCI sponsored clinical trials.

Phone: 6097997580 Fax: 6097994148 E-mail: info@theradex.com
Web: http://www.theradex.com/
Add：4365 Route 1 South, Suite 101 Princeton, NJ 08540